|Usage:||Animal Pharmaceuticals||Shelf Life:||2 Years|
pre veterinary medicine,
alternative veterinary medicine
Injection Laboratory Animal Medicine Thymopentin Acetate C10H14OSn
Thymopentin is a five amino acid fragment of thymopoietin that exhibits immunostimulatory and anticancer activities.
Thymopentin decreases iNOS activity in the treatment of Sezary Syndrome, a severe form of lymphoma.
In leukemia cells, thymopentin inhibits proliferation and colony formation and induces differentiation.
In macrophages, thymopentin increases pro-inflammatory cytokine secretion, activation of NF-κB, production of HSP72, and signaling by JNK.
Thymopentin shows clinical benefit when used as an adjuvant, improving the response rate in subjects administered hepatitis B vaccines.
It can be used in patients with malignant tumors after chemoradiotherapy, immune function impairment; treatment of hepatitis B; major surgery and serious infection; autoimmune diseases such as rheumatoid arthritis, lupus erythematosus; type II diabetes, climacteric syndrome Older and younger people with lower immune function.
(1) For patients with chronic hepatitis B over 18 years of age.
(2) various primary or secondary T cell deficiency diseases (such as children with congenital immunodeficiency disease).
(3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus).
(4) Various diseases with low cellular immune function.
Contact Person: Mrs. Lincy